Two bills in U.S. Congress this year are expected to boost e-prescriptions. This article explains the complexities that makes it so hard to implement...
EPCS
One of the unique challenges healthcare organizations have faced during COVID-19 has been new rules and procedures around managing the assets of the...
Gus Malezis, President and CEO of Imprivata, has been at the head of the company since 2016 where he’s focused on creating a sustainable company...
An independent pharmacy has spearheaded a class action suit claiming Surescripts has engaged in anticompetitive behavior which violates federal law. In the...
CynergisTek, Inc., (NYSE AMERICAN: CTEK), a leader in cybersecurity, privacy, and compliance, today announced that it has acquired Backbone Enterprises, Inc...
In theory, electronic prescribing of controlled substances should be in wide use these days, as there’s never been more pressure of doctors to be very aware of...
I’m always intrigued by anything that talks about what healthcare can do to help with the opioid crisis. So, I had to attend when KLAS Research offered a...
The following is a guest blog post by Paul Black, CEO of Allscripts, a proud sponsor of Health IT Expo. Prescription opioid misuse and overdoses are on the...
Healthcare Scene recently sat down with Paul Uhrig, Chief Administrative, Legal and Privacy Officer for Surescripts, to talk about the Opioid Crisis and how...
Back in the day, say a decade ago or so, when e-prescribing itself was a new and big deal, the feds – especially the DEA – didn’t think much of the e...
